# Deep Wise

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/deep-wise

- Industry: Healthcare
- Headquarters: Beijing, China
- Website: www.deepwise.com
- Total disclosed funding: $115M
- Latest round: Series D (Jan 24, 2025)
- Investors on record: 18

## About

Established in 2017 and based in Beijing, China, Deep Wise operates as a medical technology company that provides medical service institutions with internet medical solutions based on artificial intelligence technology. The company’s chairman, Lei Ming, obtained a master’s degree in computer science from Peking University. He is the founder of Kuwo Music and the director of Peking University’s Artificial Intelligence Innovation Center. The company’s CEO, Qiao Xin, graduated from Zhejiang University, majoring in biomedical engineering. He was the former Vice President of Siemens (China) Medical Business Unit Greater China. The company is headquartered in Beijing and has branches in Shanghai and Hangzhou. In January 2025, it raised venture funding for approximately CNY 500 million.

The company's main products include artificial intelligence-assisted diagnosis systems, cloud imaging systems, and scientific research platforms. The diagnosis system and cloud imaging system mainly provide doctors with clinical diagnosis suggestions and realize the exchange of medical data. They are currently used in early cancer screening and children's growth and development evaluation. The scientific research platform can simplify the complex process of imagingomics scientific research through machine learning technology. It uses a variety of classification models to automatically find the best combination for result analysis.

Deep Wise generates revenue by providing all-inclusive AI - based digital medical services, such as AI - assisted diagnosis and patient service solutions, to numerous medical institutions.

The company will use the venture funding to build AI-digitalized healthcare products and solutions.

## Funding rounds

- Series D, Jan 24, 2025, $69M — Legend Capital, Yuhang Jinkong Capital
- Series C, May 11, 2021 — Legend Capital, CPE Funds Management, China International Capital Corporation, Kinzon Capital
- Series C, Dec 15, 2020 — Legend Capital, New Alliance Capital, Longmen Investment
- Series C, Jun 10, 2019 — Legend Capital, Sunshine Insurance Group, Kinzon Capital, Tendence Capital, Silu Huachuang Capital, Dalton Venture, Sunland Capital, Changkejin  Investment
- Series B, Apr 2, 2018, $24M — Legend Capital, DHVC, Legend Star, Kinzon Capital, Hongdao Capital, Tendence Capital, Dalton Venture
- Series A, Nov 13, 2017, $17M — DHVC, Kinzon Capital, FengHe Fund Management, Hongdao Capital, Tendence Capital, Dalton Venture
- Series A, Mar 18, 2017, $5.1M — Kinzon Capital, FengHe Fund Management, Hongtai Aplus

## Investors

- Kinzon Capital (https://capitalatlas.ai/funds/kinzon-capital) — Series A, Series B, Series C
- FengHe Fund Management (https://capitalatlas.ai/funds/fenghe-fund-management) — Series A
- Hongtai Aplus (https://capitalatlas.ai/funds/hongtai-aplus) — Series A
- DHVC (https://capitalatlas.ai/funds/dhvc) — Series A, Series B
- Hongdao Capital (https://capitalatlas.ai/funds/hongdao-capital) — Series A, Series B
- Tendence Capital (https://capitalatlas.ai/funds/tendence-capital) — Series A, Series B, Series C
- Dalton Venture (https://capitalatlas.ai/funds/dalton-venture) — Series A, Series B, Series C
- Legend Capital — Series B, Series C, Series D
- Legend Star (https://capitalatlas.ai/funds/legend-star) — Series B
- Sunshine Insurance Group — Series C
- Silu Huachuang Capital (https://capitalatlas.ai/funds/silu-huachuang-capital) — Series C
- Sunland Capital — Series C
- Changkejin  Investment — Series C
- New Alliance Capital (https://capitalatlas.ai/funds/new-alliance-capital) — Series C
- Longmen Investment (https://capitalatlas.ai/funds/longmen-investment) — Series C
- CPE Funds Management (https://capitalatlas.ai/funds/cpe-funds-management) — Series C
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series C
- Yuhang Jinkong Capital (https://capitalatlas.ai/funds/yuhang-jinkong-capital) — Series D